82 related articles for article (PubMed ID: 26347273)
1. Response to IGF-1 Generation Test in Short Prepubertal Children Born Very Preterm or at Term.
Miles HL; Derraik JG; Chiavaroli V; Hofman PL; Cutfield WS
Horm Res Paediatr; 2015; 84(5):298-304. PubMed ID: 26347273
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
3. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic short stature and growth hormone sensitivity in prepubertal children.
Derraik JGB; Miles HL; Chiavaroli V; Hofman PL; Cutfield WS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):110-117. PubMed ID: 30908679
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and body composition in preterm born children during prepubertal ages.
Darendeliler F; Bas F; Bundak R; Coban A; Sancakli O; Eryilmaz SK; Kucukemre B; Disci R; Gokcay G; Aki S; Ince Z; Eskiyurt N
Clin Endocrinol (Oxf); 2008 May; 68(5):773-9. PubMed ID: 17980003
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
10. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
11. The endocrine consequences for very low birth weight premature infants.
Cutfield WS; Regan FA; Jackson WE; Jefferies CA; Robinson EM; Harris M; Hofman PL
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
[TBL] [Abstract][Full Text] [Related]
13. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
Smyczynska J; Hilczer M; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
[TBL] [Abstract][Full Text] [Related]
14. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
Maccario M; Tassone F; Gauna C; Oleandri SE; Aimaretti G; Procopio M; Grottoli S; Pflaum CD; Strasburger CJ; Ghigo E
Eur J Endocrinol; 2001 Mar; 144(3):251-6. PubMed ID: 11248744
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
17. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
[TBL] [Abstract][Full Text] [Related]
18. Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):469-72. PubMed ID: 11836270
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
Muñoz MT; Barrios V; Pozo J; Argente J
Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
[TBL] [Abstract][Full Text] [Related]
20. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
